Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Advice8 min read

Best Ozempic Alternatives for Weight Loss in 2026

Can't get Ozempic or looking for a cheaper option? Compare the best alternatives including compounded semaglutide, tirzepatide, and top telehealth providers.

Updated September 15, 2026

Medically reviewed on

How we review

Why People Look for Ozempic Alternatives

Ozempic (semaglutide) has become synonymous with GLP-1 weight loss, but there are several reasons people look for alternatives: the high retail cost ($900-$1,000/month), insurance denials, supply shortages, or wanting a medication specifically approved for weight loss rather than diabetes. The good news: multiple effective alternatives exist - both other medications and more affordable ways to access semaglutide itself.

Our top-rated GLP-1 providers

Our recommended telehealth providers - the same cards from our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review
3
TrimRx logo

Very Good

8.9out of 10

Limited time offer - $140 off all weight loss plans

HIPAA compliantMade in USA
  • Compounded semaglutide $149/month - same price at every dose
  • Compounded tirzepatide $259/month
  • Custom dosing with unlimited provider check-ins
  • Free consultation and free tracked delivery - often next-day

from $149/month

Telehealth GLP-1 program built around custom dosing and unlimited provider check-ins - compounded semaglutide $149/month, the same at every dose, and tirzepatide $259/month.

Read full TrimRx review

Compounded Semaglutide - Same Ingredient, Lower Cost

The most popular Ozempic alternative is compounded semaglutide - the exact same active ingredient made by licensed compounding pharmacies at $199-$400/month instead of $900+. Available through telehealth providers like altRx, TrimRx, and others. This is what most people actually use when they say they're "on Ozempic" through telehealth.

Wegovy - The FDA-Approved Weight Loss Version

Wegovy contains the same semaglutide as Ozempic but at a higher maximum dose (2.4 mg vs 2 mg) and with FDA approval specifically for weight loss. It's more expensive at retail ($1,300+/month) but is the purpose-built option for weight loss rather than off-label Ozempic use.

Mounjaro/Zepbound (Tirzepatide) - The Stronger Alternative

If you want something more effective than Ozempic, tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) targets two receptors instead of one and produces up to 22% weight loss vs Ozempic's 15%. Compounded tirzepatide is available through telehealth providers at $300-$500/month. See our tirzepatide providers page.

Shop semaglutide plans by provider

Published semaglutide plans - cheapest first, conditions under each price.

What To Know Before Starting GLP-1 Treatment

Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.

GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.

That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Woman preparing GLP-1 weight loss injection

Top Telehealth Providers for Ozempic Alternatives

The best way to access affordable Ozempic alternatives is through telehealth providers offering compounded semaglutide or tirzepatide. altRx offers both medications with transparent pricing. TrimRx offers some of the lowest pricing. SHED provides personalized treatment plans. All include physician oversight, consultations, and home delivery.

Comparing Costs: Ozempic vs Alternatives

Brand-name Ozempic: $900-$1,000/month. Brand-name Wegovy: $1,300-$1,400/month.

Compounded semaglutide: $199-$400/month. Compounded tirzepatide: $300-$500/month.

For most patients paying out of pocket, compounded options offer the best value with the same active ingredients. See our semaglutide cost guide and cheapest providers page.

How to Switch from Ozempic to an Alternative

If you're currently on Ozempic, switching to compounded semaglutide is straightforward - it's the same medication. Your telehealth provider can match your current dose.

Switching to tirzepatide requires a provider consultation to determine the appropriate starting dose. Either way, the transition is typically seamless. Take our quiz to find the right provider, or read our guide on getting semaglutide online.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)